eXoZymes Inc. Common Stock EXOZ Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -185.8%-53.3pp | -132.6%— | —— | —— | —— | |
| Return on assets | -124.4%-28.1pp | -96.4%+51.5pp | -147.9%— | —— | —— | |
| Return on invested capital | -679.1%-159pp | -520.5%— | —— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 1.3×-1.2× | 2.5×-2.0× | 4.5×-1.7× | 6.2×-0.3× | 6.5×-1.6× | |
| Quick ratio | 1.3×-1.2× | 2.5×-2.0× | 4.5×-1.7× | 6.2×-0.3× | 6.5×-1.6× | |
| Cash ratio | 0.9×-1.0× | 1.9×-2.2× | 4.1×-1.6× | 5.7×-0.2× | 5.9×-1.4× | |
| Leverage | ||||||
| Debt-to-equity | 0.8×+0.4× | 0.4×+0.1× | 0.3×+0.1× | 0.2×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0.3×+0.1× | 0.2×0.0× | 0.2×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Interest coverage | -36.1×-9.2× | -26.8×+11.8× | -38.6×-1.6× | -37×+24.2× | -61.2×+15.2× | |
| Per Share | ||||||
| Book value per share | $0.18-55.4% | $0.41-36.8% | $0.64-25.8% | $0.86-18.6% | $1.06-33.1% | |
| Valuation | ||||||
| Market capitalization | $76.8M-3.3% | $91.42M-24.5% | $121.01M+40.1% | $86.36M— | —— | |
| Enterprise value | $76.57M+3.5% | $89.67M-23.5% | $117.27M+45.1% | $80.81M— | —— | |
| Price / book | 51.5×+40.3× | 26.9×+4.4× | 22.5×+10.6× | 11.9×— | —— | |
| Free cash flow yield | -9%+2.3pp | -7.3%+1.4pp | -8.7%+2.0pp | -10.7%— | —— | |
| Earnings yield | -12.3%-2.8pp | -10%-3.1pp | -6.9%+2.0pp | -8.9%— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do eXoZymes Inc. Common Stock's ratios come from?
- Every ratio is computed from eXoZymes Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
